HIMSCAUTIOUS

EV/EBITDA

52.1x

Higher than 95% of Healthcare sector peers

Updated 1054h ago

Sector Performance

95th percentile

HIMS

52.1x

Sector Median

12.8x

Sector Avg

15.6x

📊

Deep Analysis

Hims & Hers Health, Inc. (HIMS) has a EV/EBITDA of 52.1x as of May 2026.

This places HIMS in the 95th percentile of the Healthcare sector, which has a median EV/EBITDA of 12.8x and a sector average of 15.6x. HIMS's EV/EBITDA is 307.0% above the sector median, a significant divergence that warrants closer examination. In context: A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

Frequently Asked Questions

What does the EV/EBITDA tell investors about HIMS?

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

How is the EV/EBITDA calculated?

EV/EBITDA is calculated as: Enterprise Value / EBITDA.

How does HIMS's EV/EBITDA compare to its sector?

HIMS's EV/EBITDA of 52.1x compares to a Healthcare sector median of 12.8x, placing it in the 95th percentile.

Who are HIMS's closest peers by EV/EBITDA?

The closest Healthcare peers by EV/EBITDA include: GSK (10.2x), CPRX (10.1x), ZBH (9.7x), BAX (9.4x), BIIB (8.8x).

The Formula

Enterprise Value / EBITDA

Why It Matters

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.